Shaping what's next for NF
The Children’s Tumor Foundation (CTF) USA hosted their 2024 NF Conference in Brussels, Belgium. Leanne Dib, CEO, had the chance to attend the conference as she was travelling with her family overseas.
This was an excellent opportunity for Leanne to represent the Children’s Tumour Foundation Australia and to learn more about the European NF projects and developments, as well as meet key CTF USA and Europe staff, including both Annette Bakker (CEO CTF USA) and Dariusz Adamczewski (CEO CTF Europe).
A gathering of experts and innovators. The NF Conference is a global event, attracting participants worldwide across a wide range of scientific disciplines from research and clinical backgrounds. The event is a platform for building and advancing basic, translational, and clinical research in NF, and fostering collaborations within the NF community.
With over 1000 participants both in person and online around the world, the Conference focused on drug development and improved outcomes for patients living with all types of neurofibromatosis and schwannomatosis. Inspiring event with new developments for Australia soon!
Leanne pictured with: Prof Rosalie Ferner (Guy’s and St Thomas’ NHS Foundation, England), Dr Colin Derrick (Perth Children’s Hospital, Aus) and Alexion Australia team and Dariusz Adamczewski (CEO, CTF Europe).
Leanne pictured with: Prof Eric Legius (Uni of Leuven, Belgium), Dr Jaishri Blakeley (John Hopkins Comprehensive NF Centre, USA), and Dr Natalie Pride (Children’s Hospital Westmead, Aus) and Annette Bakker (CEO, CTF USA).
To learn more about the 2024 NF Conference, click here.